Polymyxin B/Neomycin/Hydrocortisone Otic Susp Rx
Generic Name and Formulations:
Polymyxin B sulfate 10000Units, neomycin sulfate 3.5mg, hydrocortisone 10mg; per mL.
Various generic manufacturers
Indications for Polymyxin B/Neomycin/Hydrocortisone Otic Susp:
Susceptible infections of external auditory canal.
Clean ear. 4 drops in ear(s) 3–4 times daily; max 10 days.
Clean ear. 3 drops in ear(s) 3–4 times daily; max 10 days.
Cutaneous viral infections in ear (eg, herpes simplex, vaccinia, varicella zoster virus).
Perforated eardrum. Chronic otitis media. Asthma (soln). Reevaluate if no improvement in 1 week. Pregnancy (Cat.C). Nursing mothers.
Antibiotics + steroid.
Local reactions, contact dermatitis, oto- or nephrotoxicity in prolonged use, superinfection.
Susp formerly known under the brand names Cortisporin, Oticair, Otocort, Pediotic.
TC—10mL (w. dropper); Soln—10mL (w. dropper); Susp—contact supplier
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Oncology Community Expresses Concern About Medicare Advantage Step-Therapy Policy
- Progressive Telomere Shortening: An Epigenetic Biomarker of Chronic Myeloid Leukemia
- Predicting Response to Immunotherapy in Late-Stage Melanoma
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Two Independent Variables Found to Be Prognostic in Diffuse Large B-Cell Lymphoma
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Feasibility of Clinical Production of Autologous NKG2D CAR-T
- A Simplified Dose Schedule of Cetuximab as a Maintenance Therapy in Head and Neck Cancer May Reduce Drug Toxicities